NO852872L - Fremgangsmaate for fremstilling av nye tetrapyrroler. - Google Patents

Fremgangsmaate for fremstilling av nye tetrapyrroler.

Info

Publication number
NO852872L
NO852872L NO852872A NO852872A NO852872L NO 852872 L NO852872 L NO 852872L NO 852872 A NO852872 A NO 852872A NO 852872 A NO852872 A NO 852872A NO 852872 L NO852872 L NO 852872L
Authority
NO
Norway
Prior art keywords
preparation
new
tetrapyrrole
tetrapyrols
procedure
Prior art date
Application number
NO852872A
Other languages
English (en)
Other versions
NO169291C (no
NO169291B (no
Inventor
Jerry C Bommer
Bruce F Burnham
Original Assignee
Nippon Petrochemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/631,925 external-priority patent/US4675338A/en
Application filed by Nippon Petrochemicals Co Ltd filed Critical Nippon Petrochemicals Co Ltd
Publication of NO852872L publication Critical patent/NO852872L/no
Publication of NO169291B publication Critical patent/NO169291B/no
Publication of NO169291C publication Critical patent/NO169291C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO852872A 1984-07-18 1985-07-18 Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt NO169291C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/631,925 US4675338A (en) 1984-07-18 1984-07-18 Tetrapyrrole therapeutic agents
US06/728,784 US4693885A (en) 1984-07-18 1985-04-30 Tetrapyrrole therapeutic agents

Publications (3)

Publication Number Publication Date
NO852872L true NO852872L (no) 1986-01-20
NO169291B NO169291B (no) 1992-02-24
NO169291C NO169291C (no) 1992-06-03

Family

ID=27091504

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852872A NO169291C (no) 1984-07-18 1985-07-18 Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt

Country Status (9)

Country Link
US (1) US4693885A (no)
EP (1) EP0168831B1 (no)
AT (1) ATE67505T1 (no)
AU (1) AU592058B2 (no)
CA (1) CA1264740C (no)
DE (1) DE3584120D1 (no)
DK (1) DK167769B1 (no)
HK (1) HK90894A (no)
NO (1) NO169291C (no)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087622A (en) * 1982-03-30 1992-02-11 The Rockefeller University Method of controlling T3 and T4 levels in vivo with cobalt porphyrins
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
JPS63501219A (ja) * 1986-02-21 1988-05-12 ザ　ロツクフエラ−　ユニバ−シテイ 内分泌系ホルモン生成抑制用非経口投与治療組成物および方法
US5084475A (en) * 1986-02-21 1992-01-28 The Rockefeller University Methods for suppressing the endocrine system
US5063223A (en) * 1986-02-21 1991-11-05 The Rockefeller University Method of controlling androstene levels in vivo with cobalt porphyrins
US5004811A (en) * 1987-12-24 1991-04-02 Nippon Petrochemicals Company, Ltd. Tetrapyrrole aminocarboxylic acids
US5015478A (en) * 1988-08-15 1991-05-14 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US4913907A (en) * 1988-08-15 1990-04-03 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US5028594A (en) * 1988-12-27 1991-07-02 Naxcor Use of photodynamic compositions for cytotoxic effects
US4997828A (en) * 1989-02-14 1991-03-05 The Rockefeller University Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin
US4959356A (en) * 1989-05-26 1990-09-25 The United States Of America As Represented By The United States Department Of Energy Porphyrins for boron neutron capture therapy
US4997639A (en) * 1989-11-27 1991-03-05 Nippon Petrochemicals Company, Limited Method for detecting cholesterol deposited in bodies of mammals
DE4016299A1 (de) * 1990-05-21 1991-11-28 Basf Ag Chlorinderivate
EP0553116A1 (en) * 1990-10-05 1993-08-04 Queen's University At Kingston Porphyrin derivatives
JP3154742B2 (ja) * 1991-04-30 2001-04-09 日本石油化学株式会社 哺乳類の動脈硬化症治療剤
US5330741A (en) * 1992-02-24 1994-07-19 The Regents Of The University Of California Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors
JP3565442B2 (ja) * 1993-04-22 2004-09-15 新日本石油化学株式会社 哺乳類の関節炎の診断剤および／または治療剤
US5669916A (en) * 1994-09-28 1997-09-23 The General Hospital Corporation Method of hair removal
EP1091742A4 (en) 1997-02-14 2007-05-30 Miravant Pharm Inc PHOTOSENSITIVE INDIUM, FOR TPD
AU747753B2 (en) * 1997-08-05 2002-05-23 Meiji Seika Kaisha Ltd. Immunosuppression by photochemotherapy
ATE255583T1 (de) * 1998-07-10 2003-12-15 Meiji Seika Kaisha Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen
WO2000021965A1 (en) 1998-10-13 2000-04-20 Brown University Research Foundation Substituted perhalogenated phthalocyanines
US6454789B1 (en) * 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
WO2000041726A2 (en) 1999-01-15 2000-07-20 Light Sciences Corporation Noninvasive vascular therapy
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
JP2003012547A (ja) * 2001-06-27 2003-01-15 Meiji Seika Kaisha Ltd インスリン依存性糖尿病の診断剤および治療剤
WO2004002476A2 (en) 2002-06-27 2004-01-08 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
US7053210B2 (en) 2002-07-02 2006-05-30 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
US10376711B2 (en) 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use
CN2885311Y (zh) 2006-01-18 2007-04-04 郑成福 经尿道光动力疗法前列腺治疗仪
US20050085455A1 (en) * 2003-10-16 2005-04-21 Light Sciences Corporation Photodynamic therapy for local adipocyte reduction
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
EP1706095B1 (en) 2004-01-20 2008-12-24 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US20050244472A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US20050244478A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Anti-excititoxic sustained release intraocular implants and related methods
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US20050244461A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Controlled release drug delivery systems and methods for treatment of an eye
US20070059336A1 (en) * 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
US8591885B2 (en) * 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
BRPI0510485A (pt) 2004-04-30 2007-11-13 Allergan Inc implantes inibidores de tirosina cinase intravìtreos biodegradáveis
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US8455656B2 (en) 2004-04-30 2013-06-04 Allergan, Inc. Kinase inhibitors
US20050244500A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intravitreal implants in conjuction with photodynamic therapy to improve vision
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US20050244458A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US20050244462A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Devices and methods for treating a mammalian eye
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US20050244471A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US8673341B2 (en) 2004-04-30 2014-03-18 Allergan, Inc. Intraocular pressure reduction with intracameral bimatoprost implants
WO2007103427A2 (en) * 2006-03-06 2007-09-13 Wang Xiang H Medical use of bilirubin and its structural analogues
KR101456839B1 (ko) 2006-06-30 2014-11-03 유로-셀티큐 에스.에이. 광활성제 조성물 및 광활성제의 제조 방법
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US7911053B2 (en) * 2007-04-19 2011-03-22 Marvell World Trade Ltd. Semiconductor packaging with internal wiring bus
US8697610B2 (en) * 2007-05-11 2014-04-15 Schlumberger Technology Corporation Well treatment with complexed metal crosslinkers
US8853135B2 (en) * 2008-05-07 2014-10-07 Schlumberger Technology Corporation Method for treating wellbore in a subterranean formation with high density brines and complexed metal crosslinkers
NZ716349A (en) 2009-11-09 2017-07-28 Allergan Inc Compositions and methods for stimulating hair growth
WO2014071138A1 (en) 2012-11-02 2014-05-08 Lewis Thomas J Disease detection and treatment through activation of compounds using external energy
EP2956096A1 (en) 2013-02-15 2015-12-23 Allergan, Inc. Sustained drug delivery implant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
JPS53109929A (en) * 1977-03-04 1978-09-26 Nippon Oil Co Ltd Medicin for malignant tumor
JPS60500132A (ja) * 1982-09-27 1985-01-31 ヘルス・リサーチ・インコーポレーテッド 腫瘍の診断および治療のための精製されたヘマトポルフイリン誘導体ならびにその方法

Also Published As

Publication number Publication date
EP0168831A2 (en) 1986-01-22
DK326885A (da) 1986-01-19
DK167769B1 (da) 1993-12-13
ATE67505T1 (de) 1991-10-15
HK90894A (en) 1994-09-09
AU592058B2 (en) 1990-01-04
EP0168831A3 (en) 1988-05-04
DE3584120D1 (de) 1991-10-24
CA1264740A (en) 1990-01-23
NO169291C (no) 1992-06-03
AU4515985A (en) 1986-01-23
CA1264740C (en) 1990-01-23
EP0168831B1 (en) 1991-09-18
DK326885D0 (da) 1985-07-18
US4693885A (en) 1987-09-15
NO169291B (no) 1992-02-24

Similar Documents

Publication Publication Date Title
NO169291C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt
AU583373B2 (en) New tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
AU579387B2 (en) New tetrapyrrole therapeutic agents
MY110734A (en) Improvements in or relating to dioic acids.
GEP20002145B (en) Stem Cell Factor
ATE231519T1 (de) Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
CA2183871A1 (en) Platelet growth accelerator
ATE270553T1 (de) Anwendung von 1,2,4-benzotriazinoxiden zur herstellung eines arzneimittels zur behandlung von tumoren
MY103746A (en) Improvements in or relating to somatostatins
ATE125706T1 (de) Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.
RU95106821A (ru) Циклопептиды, способ их получения, фармацевтическая композиция и способ ее получения
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
EP0173664A3 (en) Biologically active benzimidazole compounds and process for their preparation
DE3570437D1 (en) 1-hydroxy-1,1-diphosphonic-acid derivatives, process for their preparation and pharmaceutical preparations, especially for the treatment of bone tumours
DE3777845D1 (de) Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie.
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
ATE265217T1 (de) Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten
CA2100720A1 (en) Medicinal composition comprising tcf-ii
IL81337A (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants,process for their preparation and pharmaceutical compositions containing them
MX9600165A (es) 3-alcoxicarbonil-tiadiazinonas, proceso para su preparacion y composiciones farmaceuticas que las contienen.
DE69330809D1 (de) Therapeutisches Agens für Neutropenie
KR840002006A (ko) 포스포르아미드 유도체, 그의 제법 및 그것을 함유하는 의약

Legal Events

Date Code Title Description
MK1K Patent expired